Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Fluticasone/Salmeterol Capsule vs Diskus in Asthma and COPD
NCT01494610Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluticasone propionate, salmeterol in asthma, chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Oct 2010; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01494610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494610.